Accès gratuit
Numéro
Med Sci (Paris)
Volume 23, Numéro 8-9, Août-Septembre 2007
Page(s) 723 - 728
Section M/S revues
DOI https://doi.org/10.1051/medsci/20072389723
Publié en ligne 15 août 2007
  1. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc group. Hepatology 1999; 30 : 1054–8.
  2. Soto B, Sanchez-Quijano A, Rodrigo L, et al. Human immunodeficiency virus infection modifies the natural history of chronic parentarally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997; 26 : 1–5.
  3. Di Martino V, Ruffat P, Boyer N, et al. The influence of human immunodeficiency virus co-infection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology 2001; 34 : 1193–9.
  4. Pol S, Lamorthe B, Trinh Thi N, et al. Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. J Hepatol 1998; 28 : 945–50.
  5. Vallet-Pichard A, Pol S. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection. J Hepatol 2006; 44 : S28–44.
  6. Rockstroh JK, Spengler U, Sudhop U, et al. Immunosuppression may lead to progression of hepatitis C associated liver disease in hemophiliacs coinfected with HIV. Am J Gastroenterol 1996; 91 : 2563–8.
  7. Cacoub P, Geffray L, Rosenthal E, et al. Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French departments internal medicine/infectious diseases, in 1995 and 1997. Clin Infect Dis 2001; 32 : 1207–14.
  8. Rosenthal E, Poirée M, Pradier C, et al. Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study). AIDS 2001; 17 : 1803–9.
  9. Pineda JA, Romero-Gomez M, Dfaz-Garcia F, et al. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology 2005; 41 : 779–89.
  10. Thio CL, Seaberg EC, Skolasky R Jr, et al. HIV-1, hepatitis B virus and risk of liver-related mortality in the multicenter cohort study (MACS). Lancet 2002; 360 : 1921–6.
  11. Puoti M, Bruno R, Soriano V, et al. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS 2004; 18 : 2285–93.
  12. Terrault N, Carter JT, Carlson L, et al. Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation. Liver Transpl 2006; 12 : 801–7.
  13. Samuel D, Duclos-Vallée JC. The difficult timing for liver transplantation in cirrhotic patients coinfected with HIV. In search for a prognosis score. Liver Transpl 2006; 12 : 699–701.
  14. Prachalias AA, Pozniak A, Taylor C, et al. Liver transplantation in adults coinfected with HIV. Transplantation 2001; 72 : 1684–8.
  15. Neff G, Bonham A, Tzakis A, et al. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl 2003; 9 : 239–47.
  16. Ragni MV, Belle SH, Im K, et al. Survival of human immunodeficiency virus-infected liver transplanted recipients. J Infect Dis 2003; 188 : 1412–20.
  17. Samuel D, Duclos-Vallée JC, Teicher E, Vittecoq D. Liver transplantation in patients with HIV infection. J Hepatol 2003; 39 : 3–6.
  18. Duclos-Vallée JC, Vittecoq D, Teicher E, et al. Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients. J Hepatol 2005; 42 : 341–9.
  19. Norris S, Taylor C, Muiesan P, et al. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Liver Transpl 2004; 10 : 1271–8.
  20. Radeke K, Fruhauf NR, Miller M, et al. Outcome after othotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis. Liver Int 2005; 25 : 101–8.
  21. Vogel M, Voigt E, Schäfer N, et al. Orthotpic liver transplantation in human immunodeficiency virus (HIV)-positive patients: outcome of the 7 patients from the Bonn cohort. Liver Transpl 2005; 11 : 1515–21.
  22. Moreno S, Fortun J, Quereda C, et al. Liver transplantation in HIV-infected recipients. Liver Transpl 2005; 11 : 76–81.
  23. Nunez M. Hepatotoxicity of antiretrovirals: incidence, mechanisms and management. J Hepatol 2006; 44 : S132–9.
  24. Duclos-Vallée JC, Feray C, Sebagh M, et al. Liver transplantation of HIV-HCV and HIV-HBV coinfected patients: a large experience in a single centre. J Hepatol 2006; 44 : S2–8.
  25. De Vera ME, Dvorchik I, Tom K, et al. Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transpl 2006; 6 : 2983–93.
  26. Ragni MV, Belle SH, Im K, et al. Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis 2003; 188 : 1405–11.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.